File(s) under permanent embargo
Hormone therapy and risk of non-vertebral fracture : Geelong Osteoporosis Study
journal contribution
posted on 2004-01-01, 00:00 authored by Julie PascoJulie Pasco, Mark KotowiczMark Kotowicz, Margaret Rogers, K Sanders, E Seeman, G NicholsonIn this population-based study, we evaluated the association between exposure to hormone therapy (HT), bone mineral density (BMD) and the prevalence of non-vertebral fractures. The study was set in a region located in southeastern Australia where complete fracture ascertainment was determined from radiological reports. Current HT use for at least 6 months was ascertained in women with non-vertebral fractures [median age 70.9 years; inter-quartile range (IQR) 66.5–75.9 years] and randomly selected controls (median age 70.8 years; IQR 65.2–75.0 years). Current HT use was documented in 20 of 262 cases and 49 of 364 controls. The odds ratio (OR) for non-vertebral fracture associated with HT use was 0.53 (95% CI 0.31–0.92). HT use was associated with 2.6–7.5% higher BMD at axial and appendicular sites. HT use is associated with a halving of risk for non-vertebral fractures and higher BMD.
History
Journal
Osteoporosis InternationalVolume
15Issue
6Pagination
434 - 438Publisher
Springer U. K.Location
Surrey, EnglandPublisher DOI
ISSN
0937-941XeISSN
1433-2965Language
engPublication classification
C1.1 Refereed article in a scholarly journalCopyright notice
2004, International Osteoporosis Foundation and National Osteoporosis FoundationUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC